Clinical Trial Update: Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a sequencing regimen of oxaliplatin/irinotecan/bevacizumab followed by docetaxel/bevacizumab in unresectable locally advanced or metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Gastric Cancer, Unresectable | Phase 2 | Status: COMPLETED